This programme is available for eligible AIA insured members who are aged 40 years and above and diagnosed with one or more of Singapore’s three most prevalent chronic conditions: diabetes, hypertension (high blood pressure), or hyperlipidemia (high blood cholesterol)
SINGAPORE: AIA Singapore and Amplify Health announced the launch of a Chronic Disease Management Programme (CDMP), which leverages technology and multi-disciplinary health expertise to help Singaporeans with diabetes, high blood pressure, or high cholesterol adopt sustainable lifestyle changes for healthier living.
The 12-month programme is available to all eligible AIA insured members from October 2025 via the Amped mobile app, at no additional cost for the first 1,500 customers.
This programme is available for eligible AIA insured members who are aged 40 years and above and diagnosed with one or more of Singapore’s three most prevalent chronic conditions: diabetes, hypertension (high blood pressure), or hyperlipidemia (high blood cholesterol).
Although Singaporeans are living longer, fewer of those years are in good health, with Singaporeans spending an average of 10 years living with illness or disability in later life.
This underscores the importance of promoting health – rather than simply treating sickness – to both enhance personal well-being and ease the strain on healthcare services and curb rising medical costs.
AIA Singapore’s CDMP supports individuals in managing chronic conditions by encouraging healthier behaviours – an approach that research suggests could save Singapore up to S$650 million in healthcare costs by 2050.
Focusing on lifestyle changes and behaviour modifications to improve long-term health, the CDMP complements the national Healthier SG initiative by providing Singaporeans with chronic conditions personalised support between GP visits.
Through a robust suite of behaviour-modification tools, tailored resources, and access to a multi-disciplinary team of dietitians, fitness coaches, and mental wellness experts, the CDMP empowers Singaporeans afflicted with a chronic condition to take control of their health and make lasting lifestyle changes.
“As Singapore’s population ages, we must shift our focus from extending lifespans to extending healthspans – and this requires us to rethink what healthcare should look like. The most powerful changes we can make for our health are often simple, everyday lifestyle changes. To support Singaporeans in making these meaningful lifestyle shifts, AIA Singapore has partnered with Amplify Health to introduce the Chronic Disease Management Programme, an important addition to our growing suite of resources that empower Singaporeans to live Healthier, Longer, Better Lives with AIA as their everyday wellness partner,” said Irma Hadikusuma, chief marketing and Healthcare Officer, AIA Singapore.
“Real health change starts when people build better habits and stick to them. Patients using Amped by Amplify Health have seen real improvements in managing chronic conditions like diabetes and high blood pressure. Doctors reported that patients stay engaged between visits, understand their diets better, and feel more supported. With AIA, we’re proud to expand this programme to even more Singaporeans—helping them take charge of their health, in a personalised way that works for them,” said Axel Baur, Chief Executive Officer, Amplify Health.
Personalised, science-driven and technology-enabled resources to drive healthier behaviours
The CDMP is available through the Amped mobile app available on iOS and Android and leverages technology, behavioural science, and personalised coaching to drive healthier habits, offering:
Unlimited text-based coaching with a multi-disciplinary team
Insightful video consultations
Personalised health plan and goal setting
A robust range of behaviour modification tools, including AI meal logging, sleep and activity tracking, curated lessons, tracking health metrics, and motivational nudges
Programme insights that highlight progress and identify improvement areas
ngapore, at no additional premiums.